Pharmacoepidemiol Drug Saf
January 2025
Background: Patient and public involvement (PPI) in research is required to improve the relevance, feasibility, and interpretability. However, research on PPIs in pharmacoepidemiology (PE) is still limited. This study aimed to provide an overview of PPI implementation in pharmacoepidemiology through an environmental scan.
View Article and Find Full Text PDFProton pump inhibitors (PPIs) are widely prescribed medications for the management of various gastrointestinal disorders, primarily gastroesophageal reflux disease (GERD) and peptic ulcers. However, recent concerns have emerged regarding their potential adverse effects on kidney function and their role in the progression of chronic kidney disease (CKD). This systematic review aims to comprehensively analyze the existing literature to assess the impact of PPI use on kidney function and CKD progression.
View Article and Find Full Text PDFToxigenic Clostridioides difficile infection (CDI) is a high concern because of its increasing prevalence, among both nosocomial infection and community-acquired infection contexts. A total of 1320 prospective stool samples collected on FecalSwab™ (Cary-Blair medium) were screened using BD Max™ CDIFF assay (BDM). Results were compared to the routine algorithm including immunochromatographic testing for glutamate dehydrogenase (GDH) and toxin A/B (tox) using C.
View Article and Find Full Text PDFOBJECTIVE To evaluate cell-mediated and humoral immune responses of calves receiving 2 doses of a dual-adjuvanted vaccine containing inactivated bovine herpesvirus type 1 (BHV1) and bovine viral diarrhea virus types 1 (BVDV1) and 2 (BVDV2) before and after exposure to BHV1. ANIMALS 24 Holstein steers negative for anti-BHV1 antibodies and proliferative cell-mediated immune responses against BHV1 and BVDV. PROCEDURES Calves were randomly assigned to 3 groups.
View Article and Find Full Text PDFIn accordance with Article 6 of Regulation (EC) No 396/2005, the Agriculture and Horticulture Development Board (AHDB) submitted a request to the competent authority in the United Kingdom (evaluating Member State (EMS)) to modify the existing maximum residue level (MRL) for the active substance deltamethrin in kale. To accommodate for the intended use of deltamethrin, it was considered necessary to raise the existing MRL. Based on the evaluation report prepared by the EMS in accordance with Article 8 of Regulation (EC) No 396/2005, EFSA concludes that the applicant provided sufficient data to derive an MRL proposal of 0.
View Article and Find Full Text PDFAccording to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance pyridaben. To assess the occurrence of pyridaben residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC and under Commission Regulation (EC) No 33/2008 as well as the European authorisations reported by Member States (including the supporting residues data). Based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out.
View Article and Find Full Text PDFIn accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Cheminova A/S submitted a request to the competent national authority in Spain to set an import tolerance for the active substance flutriafol in hops. The data submitted in support of the request were found to be sufficient to derive an import tolerance proposal of 20 mg/kg for crops under consideration. Adequate analytical methods for enforcement are available to control the residues of flutriafol in plant matrices under consideration.
View Article and Find Full Text PDFAccording to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance bromadiolone. Considering that this active substance is not authorised for use on edible crops within the EU, that no MRLs are established by the Codex Alimentarius Commission (codex maximum residue limits) and that no import tolerances were notified to EFSA, residues of bromadiolone are not expected to occur in any plant or animal commodity. Even though information on the limit of quantification (LOQ) of bromadiolone was provided by the European Union Reference Laboratories for Pesticide Residues, the available data were not sufficient to derive a residue definition for enforcement against potential illegal uses.
View Article and Find Full Text PDFIn accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Adama Irvita N.V. submitted a request to the competent national authority in Denmark to modify the existing maximum residue levels (MRLs) for the active substance tau-fluvalinate in citrus fruits.
View Article and Find Full Text PDFAccording to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance triclopyr. To assess the occurrence of triclopyr residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC as well as the authorisations reported by Member States (including the supporting residues data). Based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out.
View Article and Find Full Text PDFAccording to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance chlorpyrifos-methyl. To assess the occurrence of chlorpyrifos-methyl residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC, the MRLs established by the Codex Alimentarius Commission as well as the European authorisations reported by Member States (including the supporting residues data). Based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out.
View Article and Find Full Text PDFBackground. The role of matrix metalloproteinase-2 and -9 (MMP-2, MMP-9) in matrix degradation and metastasis has been described in various tumors. Their action is inhibited by their natural tissue inhibitor molecules TIMP-1 and -2.
View Article and Find Full Text PDFNew potential tumor markers such as matrix metalloproteinases and their inhibitors have been extensively studied during the last decades. The aim is to find prognostic markers that are measurable in easily available samples, such as serum or plasma. The proper sample type to use when measuring the levels of gelatinases and their inhibitors from blood samples is currently under critical evaluation.
View Article and Find Full Text PDFEur J Obstet Gynecol Reprod Biol
July 2004
Objective: Our aim was to assess the feasibility and short-term results of cystocele repair by the placement of a synthetic subvesical mesh secured anteriorly through the obturator foramen.
Study Design: Between 1 November 2001 and 31 July 2002, 30 consecutive patients with a grade 2 (n = 18, 60%) or 3 (n =12, 40%) cystocele were prospectively included in the study.
Results: The obturator route was feasible in all cases.
Pouch dilatation with stoma obstruction is a well-known late complication after adjustable gastric banding operations for morbid obesity. Surgical treatment of this problem usually results in removal of the band, with or without replacement by another, or in repositioning of the band via laparotomy. We present the case of a patient with late pouch dilatation and stoma obstruction after placement of a Laparoscopic Adjustable Gastric Banding system (LAGB-Bioenterics) and in whom the adjustable band was laparoscopically opened, disconnected from the access port, and repositioned more proximally on the stomach.
View Article and Find Full Text PDFBackground: Laparoscopic adjustable gastric banding is an efficient surgical method in the treatment of morbid obesity. In order to reduce the number of complications, we have modified the technique to what we term 'laparoscopic adjustable esophagogastric banding'.
Methods: Between December 1994 and July 1997, 126 laparoscopic adjustable banding procedures were carried out.
Chem Pharm Bull (Tokyo)
June 1995
A procedure for the synthesis of 2'-deoxy-2'-fluoropuromycin (1b) was developed. Ring opening of the lyxo-epoxide (4) or nucleophilic displacement of the 3'-O-mesylate (5) by an azide ion afforded two azido nucleosides, 6a and 7a. The major product (7a) was reacted with diethylaminosulfur trifluoride (DAST) to give the 2'-fluoronucleoside (8), which was converted to the 3'-aminonucleoside (9) by hydrogenation.
View Article and Find Full Text PDFThe Kaunitz' procedure in the surgical treatment of gastroesophageal reflux associated with a hiatal hernia. In patients with pathological gastroesophageal reflux associated with a hiatal hernia, simple repositioning of the lower esophageal sphincter (L.E.
View Article and Find Full Text PDFEight children and two adults with portal hypertension were treated by portal diversion surgery. In all cases recurrent gastro-intestinal bleeding from esophageal varices was the indication for shunt-operation. Still in early childhood, three of these patients had had a splenectomy in other hospitals: one emergency splenectomy for hemoperitoneum and two elective splenectomies for hypersplenism.
View Article and Find Full Text PDFThe authors present a series of thirty patients who underwent major abdominal surgery. Each patient received preoperative total parenteral nutrition (TPN) during bowel preparation. After the operation the TPN was continued immediately, even if reanimation was necessary.
View Article and Find Full Text PDFA number of well known complications and disorders force operative correction of cryptorchism, once the diagnosis of true cryptorchism is certain. In order to perform a successful orchiopexy, an extensive mobilization of the testis, up to the kidney, is sometimes needed. However, one can not always bring the testis down to the bottom of the scrotum.
View Article and Find Full Text PDFFifty patients in whom different nutritive mixtures were used are presented. Eight solutions with increasing caloric and nitrogen contents were used. The purpose of the study was to improve the nutritional status of patients prepared to major surgical interventions.
View Article and Find Full Text PDF